• Explore /
  • Poster
  • / Final analysis of a non-interventional study on cabozantinib in patients with advanced renal cell carcinoma after prior checkpoint inhibitor therapy (CaboCHECK).

Final analysis of a non-interventional study on cabozantinib in patients with advanced renal cell carcinoma after prior checkpoint inhibitor therapy (CaboCHECK).

Abstract Poster

Authors

Viktor Grünwald

Viktor Grünwald

Universitätsklinikum Essen (AöR), Westdeutsches Tumorzentrum Essen, Innere Klinik (Tumorforschung), Essen, Germany

Viktor Grünwald , Martin Boegemann , Mohammad-Reza Rafiyan , Guenter Niegisch , Marco Julius Schnabel , Anne Flörcken , Michael Maasberg , Christoph Maintz , Mark-Oliver Zahn , Anke Wortmann , Andreas Hinkel , Jochen Casper , Christopher Darr , Thomas Hilser , Matthias Schulze , Disorn Sookthai , Caroline Schoenherr , Philipp Ivanyi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04147143

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr 357)

DOI

10.1200/JCO.2022.40.6_suppl.357

Abstract #

357

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Thomas Hilser

First Author: Giuseppe Procopio

First Author: Andrew Johns

Poster

2024 ASCO Gastrointestinal Cancers Symposium

A retrospective analysis of the efficacy and safety of imatinib in elderly patients with advanced gastrointestinal stromal tumor.

A retrospective analysis of the efficacy and safety of imatinib in elderly patients with advanced gastrointestinal stromal tumor.

First Author: Takahito Awatsu